Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department has had discussions with HM Treasury on the potential merits of introducing ringfenced, multi-year capital funding upgrading for breast screening equipment, including digital breast tomosynthesis, to help ensure equitable access to modern breast screening technology.

The Government is committed to providing quality and timely care and treatment to people with breast cancer, including through equitable access to modern breast screening technology. The NHS Breast Screening Programme is seeing improvement in uptake nationally with annual data from NHS England for 2024/25 showing 70.6% of women attending their appointment.

Digital mammography, which offers high quality images, currently remains the primary screening tool for the programme. At present, digital breast tomosynthesis (DBT) is an optional tool in the assessment of screen detected soft tissue breast abnormalities following mammography.

In 2025, the UK National Screening Committee (UK NSC), who advises the Government on all screening matters, set up a working group of breast cancer screening experts to help it consider new and emerging evidence and developments that could further improve the United Kingdom’s breast screening programme. This includes exploring DBT in addition to other tests and technologies, to detect breast cancer in women with dense breast tissue. Other modalities are magnetic resonance imaging, ultrasonography, using either hand-held or automated modalities, and contrast-enhanced mammography.

If, following this work, the UK NSC makes a recommendation regarding DBT, my Rt Hon. Friend, the Secretary of State for Health and Social Care, would be asked to make a decision on whether to accept the recommendation, alongside wider policy and operational advice.

Service providers are responsible for purchasing and maintenance of breast screening equipment, and where there are issues and updates are required, they apply to the local capital investment programmes or the funding available in the current Spending Review period via the NHS England National Diagnostics Transformation Programme.